跳至主要内容
临床试验/NCT04113083
NCT04113083终止不适用

An Epidemiological Observational Study for Retrospective and Prospective Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease in Neurology and Pediatric Metabolism Clinics in Turkey

TRPHARM22 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2019年10月19日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
TRPHARM
入组人数
22
试验地点
22
主要终点
Proportion of patients with CTX possibility in Neurology Clinics

研究概览

简要总结

The prevalence of CTX in our country is estimated to be 1 / 50.000. The aim of this study is to screen more volunteers by conducting a larger screening from neurology and pediatric metabolism clinics in Turkey.

This observational study was designed retrospectively and prospectively in two stages. In the retrospective section, the patient database and / or patient files will be screened in the neurology and pediatric metabolism clinics and the patients aged 40 and below in the neurology clinics with at least two of the following will be enrolled to the study:

  • Ataxia and / or spasticity
  • Bilateral cataract (except senile cataract)
  • Intellectual limitation
  • Non-enhancing hyperintensity on T2 sections in MR imaging of dentate nuclei
  • Autosomal recessive transition pattern. (Ex: Relative Marriage)

In the pediatric metabolism centers, cases suspected of CTX and planned to apply the Mignarri Index according to the investigator's opinion will be identified.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
— 至 40 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Giving written informed consent
  • Patients in neurology clinics should have been identified with at least two of the following:
  • Ataxia and / or spasticity
  • Bilateral cataract (except senile cataract)
  • Intellectual limitation
  • Nonintensitive hyperintensity in T2 sections on MRI of the dentate nucleus
  • Forming an autosomal recessive transition pattern. (Ex: Relative Marriage)
  • In the pediatric metabolism centers, cases suspected of CTX and planned to apply the Mignarri Index according to the investigator's opinion.
  • On the day the patient signed the Informed Consent Form, the patient did not get older than 41 years of age (subjects aged 40 and under will be included in the study)

排除标准

  • The patient's ataxia and / or spasticity, cataract, intellectual limitation, and non-contrasted hyperintensity of T2 sections in MR imaging of dentate nuclei with typical MRI findings are due to a known cause other than CTX or other underlying disease.
  • The patient has participated in an interventional clinical study in the last 30 days,
  • The patient and / or his / her legal representative does not give consent to participate in the study,
  • In the opinion of the investigator, the patient is not able to fulfill the working requirements appropriately,
  • Pregnancy and / or lactation
  • If the patient was 41 years old when included in the study.

结局指标

主要结局

Proportion of patients with CTX possibility in Neurology Clinics

时间窗: 3 years

- Proportion of patients aged 40 years or younger with at least two of the following (2) in patients with a cholestanol test threshold (3.75 mg / mL) in neurology clinics: * Ataxia and / or spasticity * Bilateral cataract (except senile cataract) * Intellectual limitation * Nonintensitive hyperintensity in T2 sections on MRI of the dentate nucleus * Forming an autosomal recessive transition pattern. (Ex: Relative Marriage)

Proportion of patients with CTX possibility in Pediatric Metabolism Clinics

时间窗: 3 years

- Proportion of cases above the cholestanol test threshold (3.75 mg / mL) in pediatric metabolism centers

次要结局

  • Total of Mignarri Suspicion Index (SI)(3 Years)
  • Cholestanol Levels(3 Years)
  • Patient demographics(3 Years)
  • CTX Family History(3 Years)
  • Frequency of the systemic findings(3 Years)
  • Presence of consangunious marriage(3 Years)
  • Frequency of the neurologic findings(3 Years)

研究者

发起方
TRPHARM
申办方类型
Industry
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验